Patent Assignment
Reel/Frame 025126/0683
Merger
Recorded: 2010-10-13
Pages: 5
Assignor
NATROGEN THERAPEUTICS, INC.
Executed: 2007-04-17
Assignee
NATROGEN THERAPEUTICS INTERNATIONAL, INC.
315 E. 68TH STREET, NEW YORK, NEW YORK, 10021
Covered Property
(1)
Derivative of Isoindigo, Indigo and Indirubin for the Treatment of Cancer
Patent:
6,566,341 →
Application:
10/021,589 →